Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This step-by-step approach helps the body adjust and may reduce digestive side effects
Everyone begins at 2.5mg regardless of size
Both compounds belong to the growing class of incretin-based weight loss medications that target GLP-1, GIP, and glucagon receptors to help patients lose weight, improve blood sugar control, and reduce liver fat
The SURPASS trial series spans five major trials with combined enrollment exceeding 10,000 participants, establishing the most comprehensive GLP-1 agonist evidence base in existence
Once a bottle is opened, tablets should be used within the timeframe specified on your pharmacy label, typically remaining stable for several months if the container is properly sealed between doses
By activating both simultaneously, tirzepatide triggers overlapping but distinct metabolic responses
